PRENATAL DIAGNOSIS PANEL 2 AMNIOTIC FLUID Test
Test Cost: AED 1000.0
Test Components:
- Mucopolysaccharidoses (MPS)
Sample Condition:
Submit 10 mL (7 mL min.) Amniotic fluid in a sterile screw capped container. Ship at 18-22°C within 24 hrs. DO NOT FREEZE. Sample should be taken after 16 weeks gestation. Duly filled Prenatal genetic testing consent form (Form 18) is mandatory. Sample to be dispatched with prior appointment.
Report Delivery:
Sample Daily by 4pm; Report within 10 days
Method:
Two-Dimensional electrophoresis
Test Type:
Inborn Errors of Metabolism
Doctor:
Pediatrician
Test Department:
GENETIC
Pre Test Information:
Sample should be taken after 16 weeks gestation. Duly filled Prenatal genetic testing consent form (Form 18) is mandatory. Sample to be dispatched with prior appointment.
Test Details:
The Prenatal Diagnosis Panel 2 Amniotic Fluid Test is a diagnostic test performed on amniotic fluid during pregnancy to screen for various genetic disorders and birth defects in the developing fetus. This test is typically conducted between 15 and 20 weeks of pregnancy and can provide important information about the health of the baby.
The panel includes a comprehensive analysis of the amniotic fluid sample, which can detect chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). It can also identify other genetic disorders like cystic fibrosis, sickle cell disease, and spinal muscular atrophy. In addition to genetic disorders, the panel can screen for neural tube defects such as spina bifida and anencephaly. It can also detect certain metabolic disorders and assess the baby’s lung maturity.
The Prenatal Diagnosis Panel 2 Amniotic Fluid Test involves extracting a small amount of amniotic fluid from the womb through a needle inserted into the abdomen. The fluid is then analyzed in a laboratory using various techniques, including chromosome analysis, DNA testing, and biochemical assays.
It is important to note that this test is an invasive procedure and carries a small risk of complications, including infection or injury to the fetus. Therefore, it is typically recommended for women with a higher risk of having a baby with a genetic disorder or birth defect, such as those with a family history of genetic conditions or advanced maternal age.
The results of the test can help expectant parents make informed decisions about their pregnancy, including potential treatment options, further diagnostic tests, or preparation for the birth of a child with special needs. It is important to consult with a healthcare provider or genetic counselor to understand the implications of the test results and discuss any concerns or questions.
| Test Name | PRENATAL DIAGNOSIS PANEL 2 AMNIOTIC FLUID Test |
|---|---|
| Components | *Mucopolysaccharidoses(MPS) |
| Price | 1000.0 AED |
| Sample Condition | Submit 10 mL (7 mL min.) Amniotic fluid in a sterile screw capped container.Shipat18\u0192??22?\u00f8Cwithin24 hrs. DO NOT FREEZE. Sample should betakenafter16weeksgestation. Duly filled Prenatal genetic testing consent form (Form 18) is mandatory. Sample to be dispatched with prior appointment. |
| Report Delivery | SampleDailyby4pm;Report10days |
| Method | TwoDimensionalelectrophoresis |
| Test type | Inborn Errors of Metabolism |
| Doctor | Pediatrician |
| Test Department: | GENETIC |
| Pre Test Information | Sample should betakenafter16weeksgestation. Duly filled Prenatal genetic testing consent form (Form 18) is mandatory. Sample to be dispatched with prior appointment. |
| Test Details | The Prenatal Diagnosis Panel 2 Amniotic Fluid Test is a diagnostic test performed on amniotic fluid during pregnancy to screen for various genetic disorders and birth defects in the developing fetus. This test is typically conducted between 15 and 20 weeks of pregnancy and can provide important information about the health of the baby. The panel includes a comprehensive analysis of the amniotic fluid sample, which can detect chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). It can also identify other genetic disorders like cystic fibrosis, sickle cell disease, and spinal muscular atrophy. In addition to genetic disorders, the panel can screen for neural tube defects such as spina bifida and anencephaly. It can also detect certain metabolic disorders and assess the baby’s lung maturity. The Prenatal Diagnosis Panel 2 Amniotic Fluid Test involves extracting a small amount of amniotic fluid from the womb through a needle inserted into the abdomen. The fluid is then analyzed in a laboratory using various techniques, including chromosome analysis, DNA testing, and biochemical assays. It is important to note that this test is an invasive procedure and carries a small risk of complications, including infection or injury to the fetus. Therefore, it is typically recommended for women with a higher risk of having a baby with a genetic disorder or birth defect, such as those with a family history of genetic conditions or advanced maternal age. The results of the test can help expectant parents make informed decisions about their pregnancy, including potential treatment options, further diagnostic tests, or preparation for the birth of a child with special needs. It is important to consult with a healthcare provider or genetic counselor to understand the implications of the test results and discuss any concerns or questions. |
